01.03.2022
Acino completes acquisition of Aspen brands
Acino completes acquisition of selected trusted Aspen brands, bringing additional investment into the South African Healthcare sector. ZURICH, Switzerland, 1...
News
Growth
18.02.2022
Acino and Ferrer sign distribution agreement
Acino will commercialize several Ferrer products in the fields of neurology, urology and treatment of respiratory disorders in the Republic...
22.10.2021
Acino acquires selected Aspen brands in South Africa
ZURICH, Switzerland, 22 October 2021 – Acino and Aspen Pharmacare Holdings Limited and its subsidiaries (collectively, “Aspen”) have signed an...
16.09.2021
ADQ further strengthens its Healthcare & Pharma portfolio with agreement to acquire pharmaceutical company Acino
ADQ to acquire Acino, a Swiss-based pharmaceutical manufacturer with presence in more than 90 countries Investment builds on ADQ’s intent...
19.08.2021
Merz Therapeutics and Acino sign distribution agreement in Ukraine, CIS and Mongolia
Pharmaceutical Group of Companies Acino (Switzerland) has signed an exclusive distribution agreement with Merz Therapeutics (Germany), a business of Merz...
21.06.2021
Acino and Pharmax collaborate to align with UAE’s strategy to become a regional pharmaceutical manufacturing hub
Agreement between Swiss Acino and UAE-based EU GMP-licensed Pharmax covers the licensing, manufacturing, and supply of select Acino products across...
01.04.2021
Acino completes acquisition of select portfolio of prescription pharmaceutical products and food supplements from IlmixGroup group of companies in Russia
Zurich, Switzerland and Moscow, Russia, 1 April 2021 – Acino announced today the completion of the acquisition of select portfolio...
13.11.2020
Acino wins UNDP tender in Ukraine
Acino has won the tender of the Ministry of Health of Ukraine (MOH) through the United Nations Development Program in...
02.03.2020
Acino completes acquisition with Takeda for primary care portfolio in key emerging markets
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected...